Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: procedure (650), etiquette (1), practice (609)

Capecitabine-Irinotecan

Description: Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE and IRINOTECAN (XELIRI) Regimen • Colorectal Cancer– Capecitabine-Irinotecan (XELIRI) Indication • Treatment of advanced colorectal cancer • WHO
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Irinotecan.pdf

Bevacizumab-Fluorouracil-Folinic Acid-Oxaliplatin

Description: Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)OXALIPLATIN This regimen may require funding Regimen • Colorectal Cancer – Bevacizumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Fluorouracil-FolinicAcid-Oxaliplatin.pdf

Bevacizumab-Fluorouracil-Folinic Acid-Irinotecan

Description: Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)IRINOTECAN This regimen may require funding Regimen • Colorectal Cancer – Bevacizumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Fluorouracil-FolinicAcid-Irinotecan.pdf

Aflibercept-Fluorouracil-Folinic Acid-Irinotecan

Description: Chemotherapy Protocol COLORECTAL CANCER AFLIBERCEPT-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)IRINOTECAN This regimen may require funding Regimen • Colorectal Cancer – Aflibercept
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Aflibercept-Fluorouracil-Folinic-Acid-Irinotecan.pdf

Thyroid Cabozantinib

Description: Chemotherapy Protocol THYROID CANCER Regimen CABOZANTINIB • Thyroid – Cabozantinib (140mg-capsules) Indication • Unresectable, locally advanced or metastatic thyroid cancer where the disease
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Thyroid-Cabozantinib.pdf

Capecitabine-Streptozocin

Description: Chemotherapy Protocol NEUROENDOCRINE CAPECITABINE-STREPTOZOCIN Regimen • Neuroendocrine – Capecitabine-Streptozocin Indication • Metastatic or locally advance neuroendocrine tumours irrespective of primary site, predominantly
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Capecitabine-Streptozocin.pdf

Anastrozole-Ribociclib

Description: Chemotherapy Protocol Breast Cancer Anastrozole-Ribociclib Regimen • Breast Cancer – Anastrozole-Ribociclib Indication • Ribociclib in combination with an aromatase inhibitor is indicated
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Anastrozole-Ribociclib.pdf

Abemaciclib-Fulvestrant

Description: Chemotherapy Protocol Breast Cancer Abemaciclib-Fulvestrant Regimen • Breast Cancer – Abemaciclib-Fulvestrant Indication • Abemaciclib in combination with fulvestrant is indicated for the
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Abemaciclib-Fulvestrant.pdf

Abemaciclib-Anastrozole

Description: Chemotherapy Protocol Breast Cancer Abemaciclib-Anastrozole Regimen • Breast Cancer – Abemaciclib-Anastrozole Indication • Abemaciclib in combination with an aromatase inhibitor is indicated
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Abemaciclib-Anastrozole.pdf

Enhertu (trastuzumab deruxtecan)

Description: Chemotherapy Protocol BREAST CANCER ENHERTU (trastuzumab deruxtecan) ENHERTU is NOT the same drug as Kadcyla (trastuzumab emtansine) or generic trastuzumab). There
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Enhertu-trastuzumab-deruxtecan.pdf

531 to 540 of 698

Previous … 52 53 54 55 56 … Next